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Abstract
NICOTINIC ACETYLCHOLINE RECEPTOR DEPENDENT EFFECTS OF NICOTINE ON
HEK293T AND HBO CELLS
By James Larsen, B.A.
A thesis submitted in partial fulfillment for the requirements of the degree of Master of Science
at Virginia Commonwealth University.
Virginia Commonwealth University, 2018
Director: Vijay Lyall, Ph.D., Assistant Professor, Department of Physiology
T2R receptors are the classical bitter taste receptors which detect and transduce bitter taste
in a subset of taste receptor cells (TRCs). The TRPM5-dependent T2Rs are G-protein coupled
receptors (GPCRs) and are linked to G protein, gustducin to initiate an intracellular signaling
cascade for the transduction of bitter tastants. Nicotine is bitter. However, at present the
transduction mechanisms for the detection of nicotine in are poorly understood. Previous studies
from our laboratory using TRPM5 knockout (KO) mice demonstrated that the T2R pathway is
insufficient in explaining the taste perception of nicotine. TRPM5 KO mice elicited chorda
tympani (CT) taste nerve responses to nicotine, albeit significantly smaller than the wild type (WT)
mice and still responded to nicotine as an aversive stimulus. Following addition of mecamylamine
(Mec), a non-specific blocker of neuronal nicotinic acetylcholine receptors (nAChRs), CT
responses to nicotine were partially inhibited in both WT and TRPM5 KO mice. Mec also
decreases the aversive response to nicotine in both WT and TRPM5 KO mice. These studies led
to the hypothesis that both a TRPM5-independent and TRPM5-dependent pathways are
responsible for the detection and transduction of the bitter taste of nicotine in TRCs. The TRPM5independent pathway most likely utilizes the nAChRs expressed in TRCs and function as bitter
taste receptors for nicotine. We have subsequently demonstrated the expression of nAChRs in a
subset of TRPM5-positive TRCs. However, this mechanism is not well understood in other cell
v

types, particularly undifferentiated epithelial cells, such as HEK293T cells. The specific aims of
this project were: (i) To identify which components of T2R-dependent taste reception as well as
components of nAChRs are expressed in HEK293T cells; (ii) To determine if HEK293T cells coexpress these components; (iii) To identify if exposure to nicotine modulates the expression of
T2R and nAChR dependent components in HEK293T cells; (iv) To determine if TRCs express
functional nAChR ion channels; and (v) To determine if nAChRs are involved in the release of
neuropeptides, such as brain-derived neurotrophic factor (BDNF) in HEK293T cells. The data
obtained in HEK293T cells was compared with parallel studies on adult cultured human fungiform
taste cells (HBO) done independently by Dr. Jie Qian, a postdoctoral fellow in Dr. Vijay Lyall’s
lab. The results of combined studies on HBO and HEK293T cells indicates that TRPM5-positive
cells also co-express ionotropic nAChRs, comprising  and β subunits. The nAChRs are capable
of forming ion pores and when stimulated by nicotine and create a parallel TRPM5-independent
pathway for the detection of nicotine. Using molecular and immunocytochemical techniques, our
results demonstrate that mRNAs and proteins for bitter taste receptors and downstream
intracellular signaling components as well as subunits necessary for the formation of nAChRs are
expressed in HBO and HEK293T cells. Results demonstrated that TRPM5-positive HEK293T
cells co-expressed nAChR subunits throughout the entire population. Nicotine increased the influx
of Ca2+ in a dose dependent manner, which was somewhat reduced by the addition of TRPM5
blocker, triphenylphosphine oxide (TPPO). Both mRNA and protein expression were altered in a
biphasic pattern with a maximum increased observed at 0.5 µM nicotine with a decrease in
expression at higher concentrations. The synthesis of neurotrophic factor BDNF, required for
maturation of taste bud cells and their innervating nerves, increased in HEK293T cells exposed to
nicotine, however, nicotine did not trigger the release of BDNF. These results were then compared
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and contrasted with HBO cells to better understand the comparative effects of nicotine on both
undifferentiated and differentiated cells. The data on HBO cells is presented in the Appendix.
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Chapter 1: Introduction
1.1

Introduction to Taste
Taste or gustation is one of five traditional senses organisms have evolved in order to aid

in survival alongside sight, touch, hearing, and olfaction. Humans can distinguish between five
primary taste qualities: bitter, sweet, umami, salty, and sour (21). Together these taste qualities aid
organisms in obtaining adequate nutrients and energy while avoiding toxic substances (18, 21).
The taste quality of objects consumed are determined as dissolved molecules and ions,
referred to as tastants, stimulate taste receptor cells (TRCs) found in taste buds (47). Bitter tastants
are aversive and serve as a protective mechanism against toxic substances such as q uinine, plant
alkaloids, many non-Na+ mineral salts, alcohol, and nicotine (47). Sweet tastants signify high
energy compounds such as carbohydrates. Umami taste is elicited by L-amino acids, such as Lglutamate (MSG), indicating protein content and defined by a savory taste (52). Salty stimuli
include NaCl and other mineral salts and are often produced through the influx of Na+ across the
apical membrane of a subset of taste receptor cells. Salty taste aids in maintaining electrolyte
homeostasis through water retention and expulsion as well as maintaining blood volume (47). Sour
tastants, like bitter tastants, serve as aversive stimuli to avoid mineral and organic acids, preventing
ad libitum ingestion of acids and maintaining proper acid-base balance (47). The threshold of
tastant concentrations differs between individuals and is genetically determined, likely playing a
role in individual food preferences (11).
1.2

Tongue, Taste Bud Cells, and Taste Receptor Cells (TRCs)
The tongue is the major organ of the gustatory system, comprised of a sophisticated

structure including epithelial, neural, connective, and vascular tissues. The tongue acts as a
detector for both nutrients and toxins entering the body, sending information to the brain to prepare
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downstream organ systems for nutrient absorption and other metabolic functions. The dorsal
surface of the tongue is characterized as stratified squamous epithelium with mucosal projections
known as lingual papillae, which house the taste buds and their TRCs and give the tongue its
characteristic rough texture (2). The lingual papillae are made up of four subtypes, the filiform,
fungiform, foliate, and circumvallate papillae (2). Filiform papillae are located across the majority
of the tongue and lack taste buds. Fungiform papillae are located in the apical tip and lateral edges
of the tongue and form mushroom-shaped structures. Foliate papillae are located on the posteriorlateral portions of the tongue (2). Circumvallate papillae are located at the most posterior portion
of the tongue and form an inverted ‘V’ shape structure (2).
Taste buds are formed through clustered groups of TRCs and vary in size from 50 to 150
TRCs (45, 2). The elongated TRCs come together to form the characteristic oval shape of a taste
bud. Each TRC contains apical microvilli which house receptors for the detection of specific
tastants within the oral cavity. In order to achieve taste perception various Cranial Nerves (CN)
innervate these TRCs for communication from the taste sensing gustatory system to the brain. The
anterior two thirds of the tongue is innervated by the Chorda Tympani branch of the facial nerve
(CN VII) while the posterior third is innervated by the lingual-tonsillar branch of the
glossopharyngeal nerve (CN IX) (2). The trigeminal nerve (CN V) and the vagus nerve (CN X)
also assist in the transduction of taste (2).
These specialized TRCs respond to various taste stimuli by cell depolarization, increase in
intracellular Ca2+ concentrations ([Ca2+]i) and release of taste-specific neurotransmitter, Adenosine
Triphosphate (ATP) (20).
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Figure 1. Diagrammatic representation of a taste bud: This diagram illustrates the structure of
a taste bud; elongated taste receptor cells containing receptors specific for different taste qualities
(in this example a sweet tastant is used). Taste cells are innervated by gustatory nerve fibers (13).
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Stimuli representing each of the five taste qualities are detected by specific taste receptors.
Each taste receptor is only present on a specific subset of TBCs. Receptor binding initiates a
cascade of downstream transducing mechanisms (44). Umami, bitter, and sweet taste receptors are
G-protein coupled receptors (GPCRs) and are coupled with gustducin which begin a process to
release internal Ca2+ from the endoplasmic reticulum (ER), eventually leading to the release of
ATP (20). Sour taste receptors are H+ proton channels. Salty taste receptors are Na+-sensing ion
channels. For sour and salty tastes, entry of H+ and Na+ depolarizes the taste cell, activating
voltage-gated Ca2+ channels, allowing entry of external Ca2+ into the cell to trigger release of the
taste-specific neurotransmitter, ATP (20).
1.3

Physiology of Taste
Through DNA sequencing, a multigene family of GPCRs involved in the transduction of

bitter, sweet, and umami taste stimuli was discovered (11). The canonical taste receptors are
divided into taste receptor type 1 (T1R) and taste receptor type 2 (T2R) GPCR families, and further
differentiated through member numbers of each receptor type (11, 9). The T1R family of GPCRs
consists of T1R1, T1R2, and T1R3, which form heterodimers to create functional taste receptors
(11). Umami taste utilizes a heterodimer of T1R1 and T1R3 to detect stimuli containing L-amino
acids, indicating protein content and defined by a savory taste. Sweet taste utilizes the T1R2 and
T1R3 heterodimer to detect stimuli containing high levels of sugars, carbohydrates, sweet proteins
and artificial sweeteners (11). T1R3 KO mice have been demonstrated to display residual
responses to both umami and sweet stimuli. This indicates that, in addition to GPCRs, other taste
receptors are involved in the detection of sweet and umami stimuli (11).
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The T2R family of GPCRs is utilized for bitter taste reception and transduction. The
signaling pathways for these GPCRs are shared as gustducin is activated post stimulation through
receptor specific tastants (9).
Salty tastant detection involves both a Na+-specific and cation non-selective pathway.. The
Na+-specific pathway involves Na+ influx via amiloride-sensitive epithelial sodium channels
(ENaC) expressed in a subset of fungiform TRCs. A candidate cation non-specific cation channel
TRPV1 has been proposed as a pathway for amiloride-insensitive salt responses in rodents (15).
Finally, sour taste transduction is mediated through the PKD2L1 ion channel although other Zn2+sensitive proton channels may also be involved (11,15).
The bitter, sweet, and umami taste transduction pathways are all triggered through an
interaction between specific tastants for each taste quality and a seven transmembrane domain
GPCR. While each receptor representing its given taste quality varies between the three taste
domains, the downstream signaling cascade is shared between the three, focusing on increasing
internal Ca2+, activating non-selective cation channel TRPM5 (Transient receptor potential cation
channel subfamily M member 5) to depolarize the cell, and finally release of neurotransmitter in
the form of ATP (20). After a bitter, sweet, or umami tastant binds to its specific receptor on a
TRC, GPCRs activate heterotrimeric Gα-gustducin and its βγ partners Gβ1 and γ13. The βγ subunit
then interacts with phospholipase Cβ2 (PLCβ2) converting PIP2 to IP3 and DAG. IP3 acts as a
second messenger, interacting with IP3R3 ion channels along the ER and causing them to open,
releasing internal Ca2+ (20). This influx of Ca2+ then targets non-selective cation channel TRPM5
and gap junction hemi-channel Panx1 (20). As TRPM5 opens, Na+ freely enters the cell down the
concentration gradient, depolarizing the cell and triggering the secretion of neurotransmitter ATP
through the hemi-channel
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Figure 2. Mammalian Taste Receptors: This diagram illustrates taste receptors representing the
five taste qualities, and examples of taste stimuli that activate them (51)
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Panx1 and into the extracellular space (20). KO mice demonstrated to lack TRPM5 have been
shown to lack the ability to sense bitter, sweet, and umami taste senses through both behavioral
studies as well as through chorda tympani response recordings. ATP was confirmed as the relevant
neurotransmitter as KO mice lacking the ATP-sensing P2X ligand-gated ion channels
demonstrated no neural responses in chorda tympani and glossopharyngeal taste nerves to these
specific tastants (20).
1.3.1 Salty Taste
Salty taste reception is used to identify the nutrient and mineral concentration of food in
order to maintain ion and water homeostasis in the body. The major tastant of this taste quality is
Na+ (24). The Na+-specific taste pathway is inhibited through application of amiloride to the
anterior tongue (16). Salty tastant reception is transduced through both an amiloride-sensitive and
a amiloride-insensitive pathway which act as Na+-sensitive and insensitive pathways respectively.
The amiloride-sensitive pathway primarily functions via the amiloride-sensitive epithelial sodium
channels, ENaC. -ENaC conditional KO mice lacking -ENaC only in the taste cells have been
shown to lick NaCl solutions at a reduced rate, signifying a reduced appetitive response to salt, as
well absence of amiloride-sensitive chorda tympani response to NaCl (15).
Humans, however, have been shown to primarily detect salty tastants through amilorideinsensitive pathways, as application of amiloride shows a greatly diminished effect on salty tastant
perception in humans compared to mice. Unlike mice, humans express an additional ENaC
subunit, -ENaC subunit. This is in addition to the , β, and  subunits expressed in both human
and rodent epithelial tissues. The -subunit can form a β complex in place of the -subunit which
is approximately ten-fold less sensitive to amiloride than its β counterpart (15). These results

7

suggest that while mice primarily perceive salty tastants through amiloride-sensitive pathways,
humans rely more heavily on amiloride-insensitive pathways (15).
The suggested amiloride-insensitive pathway utilized by humans is hypothesized to be a
nonspecific cation channel TRPV1 which is permeable to Na+, K+, NH4+, and Ca2+ which are all
perceived as salty by humans (34). While the TRPV1 channel is not expressed in mice TRCs, it
has been shown to be located within trigeminal nerve endings (34). TRPV1 has also been shown
to elicit chorda tympani responses in the presence of NaCl and amiloride, while these responses
are abolished in the presence of TRPV1 antagonists, SB-366791 and capsazepine (34). At this
time, the signaling steps between TRPV1 channel activation and increase in Na+ flux across taste
receptor cell apical membrane are not known.
1.3.2 Sour Taste
The mechanism for sour taste was likely evolutionarily selected due to its ability to detect
food which is spoiled or strongly acidic. Sour tastants are detected through ion channel PKD2L1
which is expressed in a subset of TRCs known as Type III cells (26). Through cell ablation, it has
been demonstrated that ablation of Type III cells from taste buds lead to an abolished chorda
tympani responses to sour taste stimuli (26). Different mechanisms of sour taste transduction are
utilized based on the strength of the acid stimuli. Strong acids utilize Zn2+-sensitive proton
channels to allow the entry of H+ into the cell whereas weak organic acids permeate apical cell
membranes as neutral molecules and dissociate inside the cell to decrease taste receptor cell
intracellular pH (pHi) (33). In both situations, acid-induced decrease in pHi is the proximate
stimulus for sour taste transduction (33). As protons enter the cell, they interact with the K +
channel, blocking these channels and preventing a resting efflux of K+, leading to the
depolarization of the cell and eventual generation of action potentials. (18, 27, 39).
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CO2 is also detected through the sour taste pathway through apical carbonic anhydrase 4
(CA4) which is co-expressed with cells containing PKD2L1 (26). It is likely that both extracellular
and intracellular carbonic anhydrases are involved in CO2 sensing.
1.3.3 Umami Taste
The term used to denote savory taste “umami” originated from the Japanese term for
delicious, umai (32). Umami taste is classically considered to detect food which contain high levels
of L-amino acids such as L-glutamate as well as ribonucleotides such as 5’-monophosphate (IMP)
or guanosine-5’- monophophate (GMP) (28, 32). These tastants are considered to denote food with
high protein content, giving the umami taste sensation its distinct savory characteristic (28, 31).
Several receptors have been discovered to bind with umami tastants including the
T1R1/T1R3 GCPR heterodimer as well as a variant of the glutamate receptor-4 (mGluR4t), both
of which are expressed at the apical membrane of taste cells (31, 28). Glutamate functions as
neurotransmitter in many nerve cells, however these cells express their glutamate-sensitive
receptors on the basolateral membrane, creating a distinct class of cells which respond to glutamate
as a tastant compared to those that respond to glutamate as a neurotransmitter (28, 31).
Umami taste response through the T1R1/T1R3 heterodimer has been shown to be amplified
through addition of IMP and GMP (53). T1R1 KO mice were compared to T1R1/T1R3 KO mice,
where T1R1 KO mice showed a diminished but residual response to umami tastants and the
T1R1/T1R3 KO mice demonstrated a completely abolished response to umami stimuli, leading to
the conclusion that the mammalian umami receptor is a combination of both T1R1 and T1R3 (53).
At present it is not clear if variant of the glutamate receptor-4 (mGluR4t) enhance glutamate
response in the presence of IMP or GMP.
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1.3.4 Sweet Taste
Sweet taste aids in the identification of edible material containing high-energy compounds
in the forms of sugars and carbohydrates. Sweet taste transduction begins with the detection of
sweet tastants through heterodimeric GPCR T1R2/T1R3 at the apical membrane of specific sweet
TRCs (52). The receptor was identified through genetic mapping of rodent models, in which the
mouse loci, Sac, was identified as the locus responsible for sensitivity to sweets such as sucrose
and fructose (35). Human genes were then scanned until T1R3 was identified as a GCPR within
an orthologous region to the mouse Sac (35). T1R3 was hypothesized as the sweet taste receptor
until researchers observed that singular T1R3 was not enough to elicit sweet taste responses and
that heterodimeric T1R2/T1R3 was required to yield functional sweet taste receptors (35, 52, 53).
1.3.5 Bitter Taste
Bitter taste is primarily used to identify natural toxins and alkaloids in edible materials.
Mapping of DNA sequences identified the T2R (48) GPCR as the primary receptor for bitter
tastants and are located in the circumvallate, foliate, and fungiform papillae (11, 38). The T2R
family of receptors is encoded by 25-30 different genes. TRCs have been shown to express
multiple T2R genes to increase the range of bitter tastants which can be identified (11, 38).
Conditional T2R KO mice shown to lack T2R in their taste buds have been demonstrated to lack
responses to bitter tastants, such as quinine, and can no longer distinguish between quinine and
water in behavioral studies. The signaling pathway which follows tastant binding to T2R is the
same as the other GPCR-dependent taste qualities, sweet and umami. Much like the umami
pathway, the bitter taste utilizes gustducin as the G protein responsible for the previously stated
activation of PLCβ2 through the β-gustducin subunit, whereas -gustducin subunits activates
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phosphodiesterase (PDE), decreasing cAMP levels to increase [Ca2+]i, and eventually releasing
neurotransmitter ATP (11, 35, 48).
A specific T2R isoform in humans worth noting is the T2R38 isoform which affects the
ability to detect both 6-n-propylthiouracil (PROP) and phenylthiocarbamide (PTC) (19).
Sensitivity or insensitivity to these compounds has been demonstrated to effect the perceived
bitterness of compounds including ethanol (19). It is hypothesized that a heterozygous population
was evolutionarily desirable as it allows greater flexibility in bitter taste perception of the
population as a whole (19). Polymorphisms in T2R38 have been hypothesized to protect
individuals from the addictive qualities of both nicotine and alcohol as well (12).
1.4

Acetylcholine Receptors

Acetylcholine receptors (AChRs) are ligand-gated neurotransmitter receptors which bind
acetylcholine and transmit the appropriate signal (3). There are two types of AChRs named for
their major agonists, muscarinic AChRs (mAChRs) and nicotinic AChRs (nAChRs).
Acetylcholine and acetylcholine receptors are also expressed in taste cells (56, 57).
1.4.1 Muscarinic Acetylcholine Receptors
There are five subtypes of mAChRs identified as M1 through M5. M1, M3, and M5 AChRs are
G-coupled metabotropic receptors and are activated relatively slowly (milliseconds to seconds)
before activating a G protein, resulting in a signaling cascade similar to that of the GPCR signaling
cascades found in bitter, sweet, and umami taste pathways by activating phospholipase C (PLC),
generating two secondary messengers, IP3 and DAG and releasing [Ca2+]i and act as excitatory
receptors (3). M2 and M4 AChRs inhibit adenylyl cyclase causing a decrease in free cAMP as a
second messenger and act as inhibitory receptors (3). All five subtypes are found within the CNS.
M1AChRs are typically also found in secretory glands. M2 AChRs are found in cardiac tissue and
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play a role in the closing of Ca2+ channels controlling both rate and force of contraction in the heart
(3). M3 AChRs are found in smooth muscle and secretory glands. mAChRs are inhibited by a
toxin from Atropa belladonna known as atropine (3).
1.4.2 Nicotinic Acetylcholine Receptors
nAChRs are ionotropic receptors and, upon binding with its ligand, undergo a
conformational change, forming an ion pore which allows positive ions to freely flow through,
typically Na+ or K+ ions, depolarizing the cell and releasing relevant neurotransmitters (3). Unlike
mAChRs, the rate of signal transmission is much faster (microseconds) (3). While mAChRs are
function through the parasympathetic nervous system (PSNS) receptors, nAChRs function within
the both the PSNS and the sympathetic nervous system (SNS) (3). Muscle-type nAChRs are found
in neuromuscular junctions whereas neuronal-type nAChRs are found in synapses between
neurons and throughout the CNS. nAChRs are inhibited by a component of krait snake venom
known as α-bungarotoxin (3).
Functional nAChRs are pentamers consisting of various α and β subunits arranged around
a central pore (3). Each subunit consists of four major components: an extracellular NH2-terminal
domain, three transmembrane (TM) domains, a cytoplasmic loop of variable size and amino acid
sequence, and a fourth TM domain containing an extracellular C-terminal sequence (3). This fourth
TM domain is composed of β-strands that align in a configuration termed a β-barrel. There are
currently ten known α subunits, identified as α1 through α10, as well as four β subunits, identified
as β1 through β4 (3). A pentamer consisting of α4 and β2 subunits is the most common form found
in the brain (42). The only subunit capable of creating homomeric pentamers is α7 (3).
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Figure 3. Shared Taste Transduction Pathway of Bitter, Sweet, and Umami Tastes: This
diagram illustrates the transduction pathway following the binding of taste-specific ligand and
subsequent activation of G Protein Gustducin (30).
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Ligands bind to nAChRs in pockets formed between α subunits and the “back” face of an
adjacent subunit (3). Upon binding, a rotational force is produced within the β-barrel, causing TM2
to rotate from a closed hydrophobic configuration to an open hydrophilic configuration which
allows the flow of ions (3).
1.5

Nicotine
Nicotine is the principal alkaloid of tobacco, acting as a natural insecticide in tobacco

leaves (5). Within a commercial grade cigarette, there is between 10 to 30 mg nicotine (5). Tobacco
used within cigars contains between 15 to 40 mg nicotine (5). A gram of chewing tobacco contains
6 to 8 mg nicotine (5). A piece of nicotine gum contains 2 to 4 mg nicotine (5). A nicotine patch
contains between 8 to 100 mg nicotine, variant upon desired strength (5). Popular vaping product
Juul pods contain approximately 23 mg nicotine (1).
Nicotine in tobacco is primarily in the levorotary (S)-isomer and less than 1% nicotine
content is (R)-nicotine (5). Nicotine is absorbed in the body through tar droplets which are inhaled
through burning tobacco and its relative absorption rate is dependent on the pH at which it is
absorbed. Nicotine is thought to be a weak base (pKa: 8.0) and in this state will not rapidly cross
membranes (5). However, the pH of smoke from flue-cured tobacco found in most cigarettes is
acidic, leading to a more rapid absorption (5). Once tobacco smoke reaches the lungs, nicotine is
rapidly absorbed and blood concentrations rise (5). After a single puff, nicotine reaches the brain
in about 10 to 20 seconds, leading to behavioral reinforcement (5). After smoking for 9 minutes,
nicotine concentrations peak 30 minutes later (5). This peak concentration is approximately 15
ng/mL or 92 nM concentration nicotine in the blood for cigarettes, cigars, chewing tobacco,
nicotine patches and vaping liquids and 10 ng/mL or 62 nM concentration nicotine in the blood
for nicotine gum (5). These numbers can greatly vary, however, as smokers can manipulate their
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dosage of nicotine based on the size of their puff. In the case of nicotine patches, nicotine is
absorbed through the skin, where dosages and rate of release depend upon the permeability of the
skin and the rate of passage through the membrane of the many products advertised as nicotine
patches (5). All nicotine patches are believed to have an initial lag time of one hour before nicotine
appears within the blood (5).
Nicotine is metabolized through the liver into a large number of metabolites, the most
common of which is cotinine, making up between 70 to 80% of all nicotine metabolites (5).
1.6

Health Concerns Related to Nicotine
Tobacco, the primary source through which smokers intake nicotine, has been identified

by the World Health Organization as the leading cause of preventable cancers in the world with
approximately 1.27 billion tobacco users worldwide (36, 45). The Center for Disease Control and
Prevention (CDC) estimates that over 16 million Americans live with a disease caused by nicotine
intake and that worldwide over 6 million deaths are attributed to smoking and nicotine each year
(8).
The ability of nicotine to stimulate reward centers in the brain, resulting in mood elevation
and feelings of increased cognitive function, gives nicotine its initial addictive quality (36, 45).
Chronic nicotine use can lead to a desensitization of GABAergic neurons which in part lose their
ability to inhibit dopamine, reinforcing nicotine cravings (36).
Along with its highly addictive nature, nicotine is understood to adversely affect multiple
organ systems including the heart, kidneys, and lungs (36). Stimulation of nAChRs by nicotine
has been demonstrated to both initiate and progress cancers in the lungs, gastrointestinal system,
pancreas, cardiovascular system, respiratory system, immunological system, ocular system, renal
system, breasts, and both male and female reproductive systems through mechanisms which aid in
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tumor formation and growth, activation of kinases which increase resistance to chemotherapy,
increased rate of cancer metastasis, and a plethora of other symptoms (36). Secondhand smoke has
been demonstrated as an agent of chronic obstructive pulmonary disease and lung cancer (36).
Simply handling green tobacco leaves has been known to cause acute nicotine toxicity, leading to
headache, nausea, vomiting, giddiness, loss of appetite, fatigue and tachyarrythmias (36).
1.7

Nicotine activates both a TRPM5-independent and dependent pathway
Oral detection and encoding of nicotine were once thought to be primarily carried out

through the bitter taste receptors, T2R, as nicotine is an alkaloid compound. Furthermore, gustatory
neurons have been demonstrated to discriminate between nicotine and other bitter tastants (40).
TRPM5 KO mice have been shown to no longer sense quinine in solution with water but were able
to identify nicotine as an aversive stimulus (40). TRPM5 KO mice were also shown to elicit a
residual response to nicotine in chorda tympani recordings and this residual response was further
diminished through the addition of non-selective nAChR blocker, mecamylamine (40). These
results suggest that nicotine uses both a TRPM5-dependent and -independent pathway for
detection and transduction of the bitter taste of nicotine through T2Rs and nAChRs respectively.
Human fungiform taste bud cells (HBO) have been shown to co-express nAChRs on
TRPM5 positive cells, further supporting the hypothesis that both pathways work in unison in the
transduction of nicotine (43).
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4

Figure 4. Health Concerns related to Nicotine: This diagram demonstrates many of the health
consequences associated with nicotine absorption in the various muscles and organ systems of the
body (50).
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1.8

Objective of the Study

In humans, nicotine taste perception was once thought to be primarily regulated through bittertasting T2R receptors, however, evidence has shown that nAChRs play a parallel role as well.
While both TRPM5-dependent and TRPM5-independent mechanisms are expressed in bitter
sensing TRCs, the bitter taste of nicotine via T2Rs is TRPM5-dependent, whereas detection of the
bitter taste of nicotine via nAChRs is TRPM5-independent (43). Nicotine has been demonstrated
to produce a residual effect in the absence of the T2R pathway in TRPM5 KO mice and colocalization has been observed between TRPM5 and nAChR subunits in HBO cells (40).
Currently, it is unknown if Human Embryonic Kidney (HEK293T) cells contain the functional
receptors representing all of the five taste qualities and their downstream signaling components.
In addition, it is not known if HEK293T cells express nAChRs other than α5 and α7. It is also not
known if nicotine directly affects expression and function of T2Rs and nAChRs and thereby taste
perception and sensitivity to nicotine. It is also unknown how these changes in undifferentiated
cells compares to those found in adult human fungiform (HBO) cells which contain all the
receptors and signaling components associated with taste as well as nAChRs (43).
Both HEK293T and HBO cells are human cell lines however HEK293T, as embryonic and
undifferentiated cells, will serve as a control against the differentiated HBO cells in order to
identify the comparative expression and function of nAChRs in HEK293T and HBO cells. My
hypothesis is that long term exposure to nicotine will modulate both T2R and nAChR subunit
expression, exposure to nicotine in the presence of TRPM5 blocker will produce a residual
response, and that TRPM5 positive cells will also co-express nAChR subunits similar to adult
HBO studies. To test this hypothesis, we complete the following experiments: 1) RT-PCR to detect
the presence of mRNA for taste receptors, their downstream components and nAChRs,
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2)Immunostaining to determine which types of receptors are present in each cell type as well as
which cells co-express these receptors, 3)calcium imaging to understand the function of the
nAChRs, 4)qRT-PCR to determine quantifiable changes in mRNA expression in response to
nicotine, 5)Western Blot to determine how changes in mRNA expression correlate to changes in
protein expression, and finally 6)ELISA to determine the contribution of nAChRs in the release of
Brain-Derived Neurotrophic factor (BDNF) in each cell line.
The pursuit to identify mechanisms by which the bitter taste of nicotine is transduced could
have a profound effect on formulating preventative measures which could be taken towards
reducing nicotine addiction.
Chapter 2: Materials & Methods
2.1

Human Embryonic Kidney Cell (HEK293T)
HEK293T cells are human embryonic kidney cells obtained from (American Type Culture

Collection, Manassas, VA). HEK293T cells were cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM) (VWR Life Science) supplemented with 10% Fetal Bovine Serum (FBS)
(Hyclone, Logan, UT), 4-(2-hydroxyethly)-1-piperazineethanesulfonic acid (HEPES), and
Penicillin-Streptomycin (Invitrogen, Carlsbad, CA) at 37 C in 95% O2/5% CO2.
These HEK293T cells will act as a control in comparison against HBO cells as both are
human cell lines. HEK293T cells have been previously demonstrated to express nAChR subunits
α5 and α7 (81). Adult human kidney cells have also been shown to express both the α7 subunit
and T2R receptors, similar to HBO cells as well (43, 73).
2.2

Western Blots to detect the expression of nAChR and taste receptor proteins in

HEK293T Cells
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HEK293T cells were treated with 0.1 μM, 0.25 μM, 0.5 μM, and 1.0 μM nicotine in the
culture medium for 24 h at 37 C in 95% O2/5% CO2. Untreated HEK293T cells were used as a
negative control.
HEK293T cells treated with nicotine were lysed in 200 μL modified RIPA buffer, a whole
cell lysis buffer (Thermo Fisher Scientific, MA, USA). For Western blots we used 40 μg of total
protein sample. Protein samples were resolved by 10% SDS-PAGE (Bio-Rad) and transferred to
nitrocellulose membranes (Cat: 162-0094, Bio-Rad). Membranes were immune-blotted with rabbit
antiserum containing α6 antibody (Lifespan Biosciences, Inc.; LS-C119717), and a primary βactin antibody (Santa Cruz Biotechnology). Subsequently, HRP-conjugated secondary antibodies
were added: anti-rabbit antibody for α6 and anti-mouse antibody for β-actin. β-actin served as the
protein loading control. ECL Western Blotting Substrate was used for detection of HRPantibodies. CL-XPosure film (ThermoFisher Scientific #34090) was developed using an autoprocessor in a darkroom.
2.3

Detection of nAChR and taste receptor mRNA using qRT-PCR
Total RNA from HEK293T cells was purified using TRIZOL reagent (cat# 15596029,

Thermo Fisher Scientific, MA, USA) and reverse transcription was performed using HighCapacity cDNA Reverse Transcription Kit (cat# 1308188, AB applied biosystems, CA, USA).
Total RNA (4 μg) was mixed with 2 μL 10X RT Buffer, 0.8 μL 25X dNTP, 2.0 μL 10X RT
Random Primer, 1.0 μL MultiScribe Reverse Transcriptase to total volume of 20 μL per reaction.
Reverse transcription was performed at 25ºC x 10 min, then at 37ºC x 120 min, followed by 85ºC
for 5 sec and cooled to 4ºC. The products were resolved using 1% agarose gel electrophoresis to
determine the expression of nAChR and taste receptor mRNAs. The samples were diluted with 20
μL of RNase-free water to give a total volume of 40 μL. For the detection of nAChR and taste
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receptor mRNAs qRT-PCR was carried out by using Applied Biosystems reaction mixture. One
μL of 20x TaqMAn Gene Expression Assay, 10 μL of 2x TaqMan Gene Expression Master Mix,
2 μL of cDNA template and 5 L of RNase-free water was added to a test tube and briefly
centrifuged. 20 μL of PCR reaction mix solution was transferred into each well of a 96-well
reaction plate and loaded into Applied Biosystems StepOne/StepOnePlus Real-Time PCR system.
Reverse transcription were performed at 42°C x 60 min, then 70°C x 5 min and cooled to 4°C. 35
to 40 cycles of PCR amplification were performed (initial denaturation at 95°C for 1 min,
denaturation at 95°C for 15 sec, annealing for 15 sec at 53–60°C, and extension for 10 sec at 72°C).
RT-PCR products were subjected to electrophoresis on a 1% agarose gel to determine the
expression of nAChR subunits and other taste receptors. Human primers were used to detect the
presence of mRNAs for the nAChR subunits and are shown in Table 1 and Table 2. The primers
were synthesized by Thermo Fisher Scientific.
2.4

Immunoflourescence and Confocal Imaging to localize nAChRs and Taste Receptors

in HEK293T cells
HEK293T cells were plated on to a collagen coated 8-well chamber plate and fixed with
methanol for 10 min at -20C. Slides were washed with 200 μL PBS x 3 for 5 min each, then
blocking buffer with 3% donkey serum was added to the slide for 1h at room temperature.
Subsequently, individual slides were stained with rabbit antiserum containing α3, α4, α5 or 2
antibody (1:100 dilution in 3% donkey serum) or rabbit polyclonal TRPM5 antibody (1:100
dilution in 3% donkey serum). Primary antibodies against α3 (sc-5590), α4 (sc-5591), α5 (sc376979), β2 (sc-11372), and TRPM5 (sc-27366) were obtained from Santa Cruz Biotechnology,
CA, USA.
Slides were washed again with 200 L PBS x 3 for 5 min each and incubated in the dark

21

with 1 μL donkey anti-rabbit 488 (1:1000) for 1 h at room temperature. Slides were washed with
200 μL PBS x 3 for 5 min each. Secondary antibody was added to test slides and 3% donkey serum
was added to slides used as negative control and stored overnight at 4C. The slides were incubated
with DAPI (1 μg/mL) for 1 min and rinsed with PBS. Coverslip was mounted with a drop of
mounting medium. Images were then viewed using a 63x (1.4 numerical aperture) oil immersion
objective on a Zeiss LSM 700 confocal laser scanning microscope and processed using ImageJ
software with help from Dr. Jie Qian and Ms. Shobha Mummalaneni.
2.5

Calcium Imaging
HEK293T cells were plated onto glass coverslips (Warner Instruments, Hamden, CT,

USA) and grown in the incubator at 37C in 5% CO2 until they achieved a 75% confluency. Fura2AM (ab120873; 50 μg) was dissolved in 50 μL of DMSO containing 50 μL of 10% pluronic.
Fura-2AM is a membrane-permeant derivative of the Fura-2 dye in which acetoxymethyl ester
groups are attached to the dye and are later cleaved by esterases within the cell. Fura-2AM solution
was added to 3 mL of normal Ringer’s solution and placed on vortex for 10 seconds. Slides
mounted on to the bottom of the chamber and washed with 500 μL Ringer’s solution x3 containing
(in mM) 140 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, pH 7.4. Fura-2-AM solution
(650 μL) was loaded onto each slide and incubated in the dark at room temperature for 2 hours.
Slides were washed 3x with Ringer’s solution and coverslips were mounted in an experimental
chamber (RC-26GLP, Warner Instruments; 0.7 ml volume) and fitted onto a Series 20 Chamber
Platform (Warner Instruments). The cells were visualized through a water immersion 40X
objective (Zeiss; 0.9 NA) with a Zeiss Axioskope 2 plus upright fluorescence microscope. The
image was captured via a cooled CCD camera (Imago, Photonics) attached to an image intensifier
(VS4-1845, VideoScope), an epifluorescent light source (Polychrome 5, Photonics), dichroic
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filter, and 510 emission filter. The cells were excited with 340 (nm) and 380 (nm) which was
visualized at 15 s intervals. Relative changes in Ca2+ were expressed as temporal changes in FIR
(fluorescence intensity ratio; F340/F380) in individual cells relative to control. The FIR obtained in
each cell in control Ringer’s solution was normalized to 1. Changes in FIR were analyzed using
TILL Vision V3.3 software (TILL Photonics, Martinsried, Germany).
2.6

Detection of Brain-Derived Neurotrophic Factor (BDNF) Synthesis and release in

HEK293T cells using ELISA
HEK293T cells were treated with 0.1 μM, 0.25 μM, 0.5 μM, or 1.0 μM nicotine for 30
minutes in the incubator at 37 C in 5% CO2. Untreated HEK293T cells were used as negative
control.
BDNF was measured in HEK293T cell lysates and culture medium via a sandwich ELISA using
the Promega Emax immune assay (Promega Corporation, Madison, WI, USA) according to the
manufacturer’s protocol. ELISA plates were coated with anti-BDNF mouse antibody (mAb;
1:1000) and incubated overnight at 4°C. Next day the plates were washed and blocked with
Blocking Buffer (Promega). BDNF standard or sample (100 μl) was added to each well and
incubated with shaking for 2h at room temperature. The plates were washed and anti-human BDNF
pAb (1:500; 100 μl) was added to each well and incubated with shaking for 2h at room temperature.
After washing, 100 μl of diluted anti-IgY HRP (horseradish peroxidase conjugate; 1:200) was
added to each well and developed with TMB (3,3’,5,5’-tetramethylbenzidine) solution. The
reaction was stopped by adding 100 μl 1N HCl. The absorbance at 450 nm was measured using a
VICTOR 2 plate reader and the concentration of BDNF in the samples was calculated from the
standard curve and expressed as pg/2x106 cells.
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Table 1
Primers used for qRT-PCR for Taste Receptors (43)
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Table 2
Primers used for qRT-PCR to detect the mRNA of nAChRs (43)
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Chapter 3: Results
Experiments were designed to investigate nAChRs and Taste Receptor expression in
HEK293T cells, and their modulation by nicotine exposure. Parallel studies were performed in
cultured adult human fungiform (HBO) taste cells by Dr. Jie Qian to compare nicotine induced
changes in nAChRs and taste receptor expression in HBO and HEK 293T cells.
3.1.

Expression of mRNAs of nAChR subunits and Taste Receptors in HEK293T cells
As shown in Fig. 5A, using specific primers (Table 1) and RT-PCR, we detected a single

band of 132 base pairs (bp) corresponding to T1R3, a single band of 150 bp corresponding to
TRPM5, a single band of 346 bp corresponding to T2R38, and a single band of 405 bp
corresponding to TRPV1. We also detected a single band of 104 bp corresponding to α3, a single
band of 102 bp corresponding to α4, a single band of 233 bp corresponding to α5, a single band of
164 bp corresponding to β2, and a single band of 96 bp corresponding to β4 (Fig. 5B). In addition
to the expected band size of 266 bp for α6, we detected a second band of a higher size (Fig. 5B).
At present the identification of the second band is not known. These results indicate that HEK293T
cells express mRNAs of nAChR subunits and taste receptors.
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Figure 5. Gel Electrophoresis after DNA amplification via RT-PCR: Shown below is the
detection of (A) Taste Receptor and (B) nAChR subunit DNA fragments based on size and
charge after the amplification of the respective DNA segment via RT-PCR. A single band of
expected size was yielded for both each tested subunit with the exception of α6.
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3.2.

Expression of nAChR subunit proteins in HEK293T cells
The expression of nAChR proteins was detected by immunofluorescence in HEK293T

cells. As shown in Fig. 6, blue-fluorescent DAPI (4',6-diamidino-2-phenylindole) nucleic acid
stain was used to identify the nuclei of individual cells. All HEK 293T cells in the visual field were
stained with specific nAChR primary antibody labeled with the green fluorescence label. The
antibody binding was observed in both the cytosol and the cellular membrane as well as in subcompartments of cells. Primary antibody was not added to control HEK293T cells and no
fluorescence was observed. The specific nAChR subunit location in the apical cell membrane
could not be determined (Fig. 6). Dr. Jie Qian characterized the specificity of α4, α6, and 2
antibodies using respective KO mice obtained from Dr. Imad Damaj in the Department of
Pharmacology and Toxicology at VCU.
3.3.

Co-localization of nAChR subunits in individual HEK293T cells
nAChRs function as pentamers and, while homomeric forms exist, are often found in

several heteromeric combinations of α and  subunits. It was hypothesized that HEK293T cells,
which we previously demonstrated to contain nAChR subunits, would co-express many subunits
in order to form functional ion channels. HEK293T cells were dual-labeled with α5 (green
fluorescence) and β2 (red fluorescence) and all cells tested were shown to co-express both nAChR
subunits (Fig. 7). Based on results on single nAChR subunit expression, it is believe that all
subunits are co-localized within HEK293T cells.
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Figure 6. Immunofluorescence of nAChR in HEK293T Cells: Using immunofluorescence,
nAChR subunits are visualized in HEK293T cells. DAPI (blue) indicates the cell nucleus.
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Figure 7. Double-Immunofluorescence nAChR subunits and TRPM5 in HEK293T Cells:
Using double-immunofluorescence, the co-localization between nAChR subunits is visualized in
an HEK293T cells as well as co-localization between nAChR subunits and TRPM5. DAPI
indicates the cell nucleus.
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3.4. Co-localization of nAChR subunits and TRPM5 in individual HEK293T cells
Previous results from our lab demonstrated that a subset of HBO cells which expressed
nAChR also co-express TRPM5. We hypothesize that the same would occur in HEK293T cells.
As also shown in Fig. 7 most of HEK293T cells showed labelling for α6 (green fluorescence) and
TRPM5 (red fluorescence) antibodies. This suggests that both TRPM5-dependent and TRPM5independent (nAChR) receptor mechanisms for nicotine detection are expressed in same cells.
3.5.

HEK293T cells express functional nAChR channels
To test if HEK293T cells express functional nAChR channels, we recorded temporal

changes in FIR in cells loaded with Fura-2 (Fig. 8) in response to 10 and 100 μM nicotine (Fig. 9).
As shown in Fig. 8, Fura-2 loads uniformly in all HEK293 cells. Immediately, following nicotine
treatment, the cells responded with a transient increase in [Ca2+]i (indicated by a rapid increase in
FIR). Even in the continuous presence of nicotine changes in [Ca2+]i returned near their normal
value in all cells in the next 60 seconds. The changes in [Ca2+]i were also found to be dose
dependent, increasing in peak FIR value from 1.13 to 1.24 in the presence of 10 and 100 μM
nicotine respectively. In summary, the above results indicate that HEK293T cells express
functioning nAChRs. The transient changes in [Ca2+]i reflect that HEK293T cells are healthy and
regulate [Ca2+]i to maintain cell homeostasis even in the presence of nicotine.
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Figure 8. HEK293T cells loaded with Fura-2 at 340 (nm) and 380 (nm): The images
represent HEK293T cells loaded with Fura-2 uniformly distributed in the cytosol and retained
inside the cell.
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Figure 9. Ca2+ measurement in HEK293T Cells: This graph shows changes of [Ca2+]i upon
presentation of 10 and 100 μM nicotine in Ringer’s solution. The FIR values in control Ringer’s
solution were normalized to 1. Data is presented as the mean ± SEM; n=92.
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A follow-up experiment was conducted in the presence of TPPO, a TRPM5 blocker, to determine
if nicotine effects on [Ca2+]i are independent of TRPM5. In the presence of a mixture containing
10 μM nicotine and 50 μM TPPO, [Ca2+]i showed a transient increase which was less than in the
presence of 10 μM nicotine alone (Fig. 10). Peak FIR value was shown to decrease from 1.22 to
1.16, an overall decrease of 20.59%. These results indicate that a major component of the effect of
nicotine in HEK293T cells is TRPM5-independent.
3.6.

Nicotine-induced changes in nAChR subunit and Taste Receptor mRNAs in

HEK293T cells
To determine the effects of nicotine on nAChR mRNA expression, cultured HEK293T
cells were incubated with nicotine at 0.25, 0.5, and 1.0 μM for 24 hours. Changes in nAChR
mRNAs were measured using qRT-PCR. nAChR α5 increased significantly at 0.25 (p = 0.002)
and 0.5 μM nicotine (p = 0.001). However, relative to 0.5 M nicotine, no further increase in its
expression was observed at 1 M nicotine (Fig. 11A). nAChR α6 increased significantly at 0.25
(p <0.001), 0.5 (p <0.001) and 1.0 μM nicotine (p = 0.003). However, relative to 0.5 M nicotine,
no further increase in its expression was observed at 1 M nicotine (Fig. 11B). nAChR β2
increased significantly at 0.5 (p = 0.025) and 1.0 μM nicotine (p = 0.002). However, relative to
0.5 M nicotine, no further increase in its expression was observed at 1 M nicotine. These results
suggest that nicotine produces maximum increase in α5, α6, and 2 nAChR mRNAs at 0.5-1 μM
nicotine (Figure 11C).
Next, we also tested the effect of nicotine on the mRNA of human bitter taste receptor
T2R38 under the same conditions. T2R38 increased significantly at 0.25 (p = 0.001), 0.5 (P
<0.001) and 1.0 μM nicotine (p <0.001). In this case the increase in T2R38 mRNA at 1 M
40

Figure 10. Ca2+ measurement in HEK293T Cells in the presence of TRPM5 Blocker: This
graph shows changes of [Ca2+]i upon presentation of 10 μM nicotine and 50 μM TPPO, a
TRPM5 blocker, in Ringer’s solution. The FIR values in control Ringer’s solution were
normalized to 1. Data is presented as the mean ± SEM; n=12.
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nicotine was less than at 0.5 M nicotine (p=0.00029). Thus nicotine produced a maximum
increase in T2R38 mRNA expression at 0.5 μM nicotine in a biphasic manner (Figure 12). These
results suggest that both nAChR and taste receptors change dynamically with nicotine exposure.
We hypothesize that changes in their expression with nicotine exposure may reflect adaptation to
the taste of chronic bitter taste of nicotine under chronic exposure.
3.7.

Effect of nicotine on nAChR protein expression in HEK293T cells
A western blot was performed to determine if there was a correlation between increased

mRNA expression (Figure 13) and an increase in protein expression. nAChR α6 was tested as the
differential change in mRNA between HEK293T and HBO cells were observed in this subunit.
HEK293T cells were incubated with 0.25, 0.5, and 1.0 μM nicotine for 24 hours. nAChR α6
increased significantly at 0.25 (p = 0.0196), 0.5 (p = 0.0172), and 1.0 μM nicotine (p = 0292) with
a maximum increase at 0.5 μM.
3.8.

Effect of nicotine on BDNF concentration and release in HEK293T cells
ELISA was conducted to determine the effect of nicotine on synthesis and release of

BDNF, a neuropeptide involved in maturation of taste buds and nerve formation synaptic
connections between the taste buds and cranial nerves, typically activated through acetylcholine.
Treating HEK293T cells with 0.25 μM nicotine significantly increased the content in cell lysate
that remained elevated at 0.5 and 1.0 μM nicotine. Relative to control, treating HEK293T cells
with 0.25, 0.5 and 1.0 μM nicotine produced a small but dose dependent increase in BDNF
concentration in the both the cell lysis and media (Figure 14). However, nicotine was shown to be
a poor signal for the release of BDNF as the majority of BDNF remained within the cell.
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Figure 11. qRT-PCR for nAChR subunit mRNA expression: The values are presented as the
mean ± SEM mRNA nAChR subunit expression between negative control and 24 hour nicotine
exposure at variable concentrations. The asterisk represents a significant difference (ANOVA <
0.05) between control and treatment conditions. Figure data was normalized to GAPDH. (A) α5
mRNA expression was shown to significantly increase at 0.25 μM and 0.5 μM nicotine
(ANOVA=0.002 and 0.001 respectively). (B) α6 mRNA expression was shown to significantly
increase at 0.25 μM, 0.5 μM, and 1.0 μM nicotine (ANOVA<0.001, <0.001, and 0.003
respectively). (C) β2 mRNA expression was shown to significantly increase at 0.5 μM and 1.0
μM nicotine (ANOVA=0.025 and 0.003 respectively).
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Figure 12. qRT-PCR for T2R38 mRNA expression: The values are presented as the mean ±
SEM mRNA T2R38 mRNA expression between negative control and 24 hour nicotine exposure
at variable concentrations. The asterisk represents a significant difference (ANOVA < 0.05)
between control and treatment conditions. Figure data was normalized to GAPDH. T2R38
mRNA expression was shown to significantly increase at 0.25 μM, 0.5 μM, and 1.0 μM nicotine
(ANOVA =0.001, < 0.001, and <0.001 respectively).
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Figure 13. The effect of Nicotine on nAChR subunit protein expression in HEK293T Cells:
(A) Protein expression captured through ImageJ software of Western Blot results. (B)This data
shows HEK293T cells which were treated with varying amounts of nicotine for 24 hours and the
expression level of nAChR α6 subunit protein was measured using Western Blot analysis. The
asterisk represents a significant increase [p = 0.020, 0.017, and 0.029 respectively] in expression
at 0.25 μM, 0.5 μM, and 1.0 μM nicotine. The values of protein expressions are normalized to βActin.
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Fig 14. Effect of Nic on BDNF synthesis and release in HEK293T cells: This graph shows
changes to BDNF synthesis and release based on nicotine exposure in HEK293T cells. Relative
to control, at 0.25 μM Nic, BDNF concentration in cell lysate was significantly increased (p =
0.0001), and remained elevated at 0.5 μM (p = 0.0331) and 1.0 μM Nic (p = 0.0041). Relative to
control at 0.25 μM, 0.5 μM, and 1.0 μM Nic, a small but significant increase in the BDNF
concentration was observed in the media (p = 0.0001). The values are mean ± SEM of triplicate
measurements.
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Chapter 4: Discussion
The nAChRs have been shown to be expressed in rat taste cells, mouse small intestine
(STC-1) cells in culture, enteroendocrine cells of the mouse gut, HBO cells, and in this study we
present new results that demonstrate their expression in HEK293T cells (58, 59, 76). In relation to
taste transduction, nAChR-positive TRCs co-expressed in T2R38 (59). While only a specific
subset of cells were found to express nAChRs in HBO and mouse enteroendocrine gut cells, the
entire population of STC-1 and HEK293T cells expressed nAChRs (58, 59, 76). Furthermore, all
nAChR-positive cells co-expressed TRPM5. Sweet, bitter, umami, salty and sour taste receptors
are expressed in distinct non-overlapping taste receptor cells. This is a unique property of
differentiated TRCs versus undifferentiated HEK293T cells. The nAChRs are expressed in
TRPM5-positive and T2R38-positive HBO cells. Thus, nAChRs also serving as bitter taste
receptors for nicotine are expressed in cells which detect bitter taste via T2Rs. Thus, both TRPM5dependent and TRPM5-independent pathways are present in same T2R-TRPM5-positive TRCs.
In a patch clamp study conducted on isolated rat taste receptor cells, 2 out of 10 (20%) taste
cells responded with an increase in inward current when exposed to nicotine (58). Nicotine (0.2
mM) elicited inward currents that were inhibited in the presence of 0.3 mM Mecamylamine (58).
The nicotine-induced current reversed near -10 mV, as expected for poorly selective nAChR
channels (58). Thus, nicotine elicits currents in a subset of fungiform TRCs by activating nAChRs
(58). These currents are most likely related to the CT responses to nicotine and their sensitivity to
mecamylamine. A similar fraction of TRCs was found to express nAChR proteins in
immunofluorescence studies. Only 2 of 11 HBO cells (18%) investigated were observed to express
the α5 subunit. This further strengthens the hypothesis that differentiated taste bud cells express
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specific taste receptors in non-overlapping subsets of TRCs (43). As undifferentiated cells, the
entire population of the HEK293T cells demonstrated the expression of nAChRs.
In rodents, CT responses to nicotine were inhibited by topical lingual application of 8chlorophenylthio (CPT)-cAMP, a membrane permeable cAMP analog, and loading taste cells with
[Ca2+]i by topical lingual application of ionomycin and CaCl2 (58). In contrast, CT responses to
nicotine were enhanced when TRC [Ca2+]i was reduced by topical lingual application of BAPTAAM (58). This indicates that a different transduction mechanism is used to transduce TRPM5independent but nAChR-dependent receptor mechanism that is regulated by cAMP and [Ca2+]i.
However, further experiments are needed to determine if nAChR-dependent mechanism also leads
to ATP release following nicotine stimulation. Since nicotine elicits CT nerve responses in
TRPM5-KO mice, it is likely that, if not ATP, another neurotransmitter may be involved. In
addition, correct identification of nicotine remains above chance in rats given both nicotine and
mecamylamine, suggesting the importance of this TRPM5-dependent pathway in transduction of
nicotine as TRPM5 is not blocked by mecamylamine (40).
We have demonstrated that HEK293T cells express the necessary mRNAs involved in both
TRPM5-dependent (Fig. 5A) as well as TRPM5-independent pathway (Fig. 5B), similar to
previous results found in HBO cells (S1 Fig.) (43). However a key distinction is made through
immunofluorescence when comparing the populations of HBO and HEK293T cells which
endogenously express both receptor types. HEK293T cells express each nAChR subunit as well
as TRPM5, a downstream signaling component of umami, sweet, and bitter taste reception
throughout the population (Figs. 6 and 7), while HBO cells express these proteins uniquely in
specific subsets of non-overlapping cells (S2 Fig.) (43). While the entirety of the population of
HEK293T cells was found to express α5, HBO cell results demonstrated only 2 of 11 cells (18%)
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expressed the α5 subunit (43). The subset of nAChRs-positive HBO cells was found to co-express
TRPM5 specifically while nAChR-negative cells did not, unlike the complete expression seen
throughout the HEK293T population (43). In addition, a subset of HBO cells responded to an
increase in [Ca2+]i when exposed to nicotine in a dose-dependent manner (S4 Fig.) whereas the
entire population of HEK293T cell demonstrated an increase in [Ca2+]i with nicotine (Fig. 9).
Comparison of CT responses to nicotine between WT and TRPM5 KO mice, the KO mice
showed a diminished but residual response relative to WT mice (58). A similar decrease in CT
response was noted when comparing control WT mice to WT mice in which the tongue was
stimulated with a solution containing nicotine + mecamylamine, a non-selective nAChR blocker
(58). In HBO cells at nicotine concentrations less than 5 mM, nAChRs and T2Rs each account for
about 50% of the total response to nicotine (58). Above 5 mM nicotine, the T2R fraction reached
its maximum response and the nAChRs begins to predominate (58). Consequently at 10 mM
nicotine the T2R response fraction decreases to 41% and at 20 mM nicotine it is 35% and 30% in
the high concentration limit (58). Since the TRPM5-dependent response (T2R component) is
mecamylamine-insensitive, in the presence of mecamylamine, the T2R component in the high
concentration limit represents a higher fraction of the CT response, i.e. 41% (58). Thus the two
pathways, TRPM5-independent and TRPM5-dependent, detect nicotine at different concentration
ranges. These results were mirrored in our own HEK293T studies in calcium imaging, where the
addition of TPPO (50 µM), a TRPM5 blocker, reduced peak response to nicotine by 21% in low
concentrations of nicotine (10 µM). A higher concentration of nicotine was used in recording CT
responses by directly stimulating the rodent tongues and require higher concentrations of nicotine
to elicit a CT response. It is hypothesized that both blockers would have a similar impact on each
of the cell types. HEK293T cells are commonly used to overexpress nAChRs to study channel
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function and regulation. The presence of both a TRPM5-independent and TRPM5-dependent
pathways for nicotine facilitates an extended range of concentrations through which nicotine can
bind to relevant receptors.
In the kidney, α7 nAChRs are expressed in the proximal and distal tubules and exposure to
nicotine in these cells has been demonstrated to be involved in the progression of chronic kidney
disease (CKD) (73, 74). Identification of nAChRs within HEK293T, an embryonic kidney cell
line, could suggest a link between over express of nAChRs and kidney disease.
In addition, Ca2+ influx along with cell depolarization mediated by some types of nAChRs
can produce neurotransmitter and hormone release. The taste system is inherently plastic due to
the turnover of receptor cells every 10 to 14 days in humans (79). Under the influence of varying
environmental factors, different proportions of receptor membrane components can be
incorporated as new taste receptor cells dependent upon the hormonal, dietary, and developmental
status of the animal (79). As taste receptor cells are replaced approximately every 10 to 14 days in
humans, the effect of nicotine exposure on synthesis and release of BDNF raises a concern. In
enteroendocrine cells, BDNF plays a key role in survival and growth of enteric neurons,
augmentation of enteric circuits, and stimulation of intestinal peristalsis and propulsion (76). In
taste, BDNF is responsible for the formation and maturation of TBCs and innervating nerve fibers
(43). BDNF-KO mice were demonstrated to lack the sense of taste and taste transduction (80). Our
results demonstrated that, while in both HBO and HEK293T exposure to the nicotine increased
BDNF synthesis, only HBO cells released significant amount of BDNF in response to nicotine. In
HEK293T cells, a lack of nicotine induced BDNF release may signify a decreased ability of
undifferentiated cells to release hormones and neurotransmitters.
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In vitro experiments conducted in this study mimic physiologically relevant concentrations
of nicotine in both short and long-term exposure to HEK293T ad HBO cells. Short-term exposure
to nicotine concentrations can reach mM amounts based on the source through which nicotine is
ingested orally, in particular while chewing tobacco (5). In HBO cells, these concentrations were
demonstrated to elicit significant [Ca2+]i flux responses (43). In CT recordings in rodents mM
nicotine concentrations elicited dose-dependent increase in the CT response. Long-term exposure
to nicotine typically increases nicotine concentrations in human saliva in the range of 0.1 to 0.2
μM. When HEK293T and HBO cells were exposed to nicotine at sub-micromolar concentrations
in vitro, nicotine induced up-regulation of nAChR mRNA and protein expression (43). Exposure
of nicotine in HEK293T also demonstrated up-regulation of T2R38 expression. An important
distinction arises when comparing the fold-change in mRNA and protein expression between HBO
and HEK293T cells. Nicotine up-regulated 6 mRNA expression to approximate 1.6 and 20-fold
in in HEK293T and HBO cells, respectively (43) (S5 Fig.). These changes in nAChR expression
would likely increase the sensitivity to nicotine within the taste system via the TRPM5independent but nAChR-dependent pathway. In addition to changes in nAChRs, nicotine also
increased T2R38 expression in HEK293T cells in a biphasic manner, with a relative maximum at
0.5 μM nicotine, same as with the nAChR subunits. T2R38 was not tested on HBO cells, but it is
hypothesized to increase in a similar manner seen in HEK293T cells. At present it is not clear if
the expression of other T2Rs is increased by acute or chronic exposure to nicotine in HEK293T or
HBO cells.
Our study indicates that many nAChR subunits are expressed in HEK293T cells
endogenously. These native nAChRs may influence the characteristics of over-expressed nAChR
channels and the expression of these nAChRs can be readily influenced through short-term
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nicotine exposure as shown in our qRT-PCR studies. Up-regulation of these nAChR subunits in
HEK293T and HBO cells was shown to occur with nicotine exposure as low as 0.25 µM nicotine,
mimicking serum and saliva nicotine concentrations in smokers (5, 43). Up-regulation of nAChRs
has also been observed in human dermal fibroblasts as well and in human squamous lung cancer
cell lines (77, 78).
Further investigations into nAChRs and their role in parallel with TRPM5-dependent
pathways should focus on determining if nicotine effects on BDNF release are blocked by nAChR
blocker, mecamylamine. Another focus be to resolve if bitter taste of ethanol is also transduced
via nAChRs and additive effects of nicotine and ethanol on the taste system occur via nAChRs
expressed in TRCs. Next, nicotine induced release of ATP could be measured in HBO cells to
understand if both TRPM5-dependent and TRPM5-independent pathways the use of this tastespecific neurotransmitter elicit neural responses to nicotine stimulation. A final focus should
consider long-term effects of nicotine exposure on expression of relevant receptors as well as their
recovery upon nicotine abstinence.
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SUPPLEMENTAL FIGURES
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1

Supplemental Figure 1. Expression of nAChR subunits, taste receptors, and intracellular
signaling intermediates in HBO (43):
(A) mRNAs for the α3, α4, α5, α6, α7, β2, and β4 were detected in HBO cells. (B) In addition,
mRNAs for T1R1, T1R3, T2R38, and TRPM5 were detected in HBO cells.
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2

Supplemental Figure 2. Immunofluorescence staining of α5 in HBO cells (43):
Shows immunostaining of α5 HBO cells using 20x and 40x objectives (total 200x and 400x
magnification). The panels show merged confocal images of DAPI (blue) and secondary
antibody fluorescence (green). The horizontal red lines represent 10 μm.
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3

Supplemental Figure 3. Co-localization of α and Β subunits in HBO cells and Colocalization of α5 subunit with TRPM5 in HBO cells (43):
Dual immunostaining was used to co-localize α and β subunits in individual HBO cells. Show
immunostaining of α5 with β2. The panels show confocal images of α5 (green), β2 (red), DAPI
(blue), and merged images of DAPI and dual fluorescence labels. Dual immunostaining was used
to co-localize α6 subunit with TRPM5 in individual HBO cells. Show confocal images of α6
(green), TRPM5 (red), DAPI (blue), and merged images of DAPI and dual fluorescence labels.
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Supplemental Figure 4. Effect of Nicotine and mecamylamine on temporal changes in
[Ca2+]i in individual HBO cells (43):
(A) Shows a representative HBO cell that responded with a dose-dependent increase in FIR
when stimulated with 0.01, 0.05 and 1.0 mM Nic. (B) Shows another representative HBO cell
that responded with an increase in FIR in the presence of 1 mM Nic. Mec (50 μM) inhibited the
Nic-induced increase in FIR. In each cell, the FIR was normalized to 1 with respect to its value
under the control conditions.
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Supplemental Figure 5. Effect of Nic exposure on the nAChR subunit mRNA expression
level in HBO cells (43):
After 24h Nic treatment. Relative to control, at 0.25 μM Nic the *p values for α3, α5, Α α6, β2,
and β4 mRNAs were 0.0111, 0.0306, 0.0017, 0.0239, and 0.0173, respectively. Relative to
control, at 0.50 μM Nic the *p values for α3, α5, α6, β2, and β4 mRNAs were 0.0022, 0.0473,
0.0014, 0.0049, and 0.0141, respectively. Relative to control, at 1.0 μM Nic the *p values for α3,
α5, α6, β2, and β4 mRNAs were 0.0194, 0.0055, 0.0013, 0.0236, and 0.0003, respectively.
Relative to 0.25 μM Nic, at 0.50 μM Nic the *p values for α6 and β 4 were 0.0039 and 0.0024.
Relative to 0.50 μM Nic at 1.0 μM Nic the *p values for α6, β, and β4 were 0.0192, 0.0144, and
0.0046, respectively.
66

6

Supplemental Figure 6. Effect of Nicotine and on α6 protein expression in HBO cells (43):
HBO cells were treated with Nic (0.25–1.0 μM) for 24h. Western blots were developed using
specific α6 antibodies. The fold change in protein expression was calculated with respect to βactin. The values are means of triplicate measurements.
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7

Supplemental Figure 7. Effect of Nicotine on BDNF synthesis and release in HBO cells (43):
HBO cells were treated with 0.25, 0.50, and 1.0 μM Nic for 30 min. Following that BDNF
concentration was measured in cell lysate and the media. Relative to control BDNF
concentration in cell lysate increased at 0.25 μM Nic (p = 0.0274) and decreased at 0.5 μM Nic
(p = 0.0055). No significant increase in BDNF concentration was observed at 0.25 μM Nic,
however, at 0.5 μM Nic, BDNF concentration was significantly increased relative to control (p =
0.0001). Relative to control at 1.0 μM Nic, a small but significant increase in the BDNF
concentration was observed in the media (p = 0.0004). The p values for the changes in total
BDNF content for 0.25, 0.5 and 1.0 μM Nic were 0.0289, 0.0002, and 0.0014, respectively. The
values are mean ± SEM of triplicate measurements
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